2 results
Approved WMOCompleted
Primary objective1. To demonstrate the efficacy of at least one of three doses of ACT-128800 as compared to placebo in patients withrelapsing-remitting multiple sclerosis (RRMS) on the cumulative number of new gadolinium-enhancing lesionsper patient…
Approved WMORecruiting
The study aim is to examine different doses of Naronapride film-coated tablets (for oral intake) versus placebo in patients with idiopathic or diabetic gastroparesis. In previous clinical trials, Naronapride has been administered to more than 900…